Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of AstraZeneca's AZD-3427?
AZD-3427 is commercialized by AstraZeneca, with a leading Phase II program in Congestive Heart Failure (Heart Failure). According to Globaldata,...
Data Insights
Risk adjusted net present value: What is the current valuation of AstraZeneca's AZD-3427?
AZD-3427 is commercialized by AstraZeneca, with a leading Phase II program in Pulmonary Hypertension. According to Globaldata, it is involved...